Suspension of the Marketing Authorisations and withdrawal of fenspiride based drugs (Pneumorel and Eurespal) from the market
All the news from Servier Group
Autoimmune Diseases: first option within global license agreement exercised for clinical development of OSE-127
All year round, and especially on February 4th, Servier is committed to the fight against cancer
Servier Ukraine organized the first hackathon for students
Autism research: launch in Europe of two phase 3 clinical studies in children aged 2 to 6 years and 7 to 17 years
[Mécénat Servier] Muriel’s testimony on her Solidarity Leave® with Planète Urgence in Benin
Servier joins the International Federation of the Pharmaceutical Industry (IFPMA)
World Pancreatic Cancer Day: Demand Better together!
Mécénat Servier’s ChildSight project launched in Vietnam